Lee Ainslie Wave Life Sciences Ltd. Transaction History

Maverick Capital LTD

$5.07 Billion
Q2 2024

A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Maverick Capital LTD holds 7,669,361 shares of WVE stock, worth $63.6 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

7,669,361

Previous 7,688,079 0.24%

Holding current value

$63.6 Million

Previous $47.4 Million 19.32%

% of portfolio

0.75%

Previous 0.94%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $81,984 - $121,292	-18,718 Reduced 0.24%	7,669,361 $38.3 Million
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $2.69 Million - $5.2 Million	-759,725 Reduced 8.99%	7,688,079 $47.4 Million
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $7.71 Million - $12.7 Million	1,853,485 Added 28.11%	8,447,804 $42.7 Million
Q3 2023 Nov 14, 2023	SELL	$3.56 - $5.75 $8,754 - $14,139	-2,459 Reduced 0.04%	6,594,319 $37.9 Million
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $1.79 Million - $3.16 Million	-500,886 Reduced 7.06%	6,596,778 $28.6 Million
Q4 2022 Feb 14, 2023	SELL	$3.18 - $7.0 $2.25 Million - $4.95 Million	-707,555 Reduced 9.07%	7,097,664 $49.7 Million
Q2 2022 Aug 15, 2022	BUY	$1.23 - $3.25 $2.72 Million - $7.19 Million	2,211,830 Added 39.54%	7,805,219 $25.4 Million
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $7.54 Million - $12.4 Million	2,400,000 Added 75.16%	5,593,389 $17.6 Million
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $514,711 - $749,436	105,258 Added 3.41%	3,193,389 $15.6 Million
Q2 2021 Aug 16, 2021	BUY	$5.65 - $7.47 $27,854 - $36,827	4,930 Added 0.16%	3,088,131 $20.6 Million
Q1 2021 May 17, 2021	BUY	$5.61 - $12.01 $17.3 Million - $37 Million	3,083,201 New	3,083,201 $17.3 Million

Others Institutions Holding WVE

# of Institutions

146

Shares Held

93.1M

Call Options Held

33K

Put Options Held

57.2K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $720M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track Lee Ainslie's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Account